Post-authorization Safety Reporting

Post-Authorization Safety Reporting is a regulatory pharmacovigilance process that involves the systematic collection, evaluation, and submission of safety data on medicinal products following their regulatory approval to identify and mitigate previously unrecognized risks.

21

Publications

660

Citations

165

Authors

109

Institutions

Publications per year

2017–2026

9

Authors

165

  1. TJ
    Thijs J. Giezen

    Utrecht University, Netherlands

    2 publications · 326 citations

    2

    h-index

  2. TC
    Toine C. G. Egberts

    Utrecht University, Netherlands

    2 publications · 326 citations

    2

    h-index

  3. HG
    Hubert G. M. Leufkens

    Utrecht University, Netherlands

    2 publications · 326 citations

    2

    h-index

  4. AK
    Aukje K. Mantel‐Teeuwisse

    Utrecht University, Netherlands

    2 publications · 326 citations

    2

    h-index

  5. MK
    Meredith K. Chuk

    Center for Drug Evaluation and Research, United States

    2 publications · 38 citations

    2

    h-index

1–5 of 165

Venues

  1. JAMA

    2 publications · 279 citations

    2

    h-index

  2. Blood Coagulation & Fibrinolysis

    1 publications · 17 citations

    1

    h-index

  3. Frontiers in Pharmacology

    1 publications · 20 citations

    1

    h-index

  4. Journal of Clinical Oncology

    1 publications · 18 citations

    1

    h-index

  5. The Oncologist

    1 publications · 13 citations

    1

    h-index

1–5